InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,129.17
(
1.28%
)
US TECH 100
17,418.80
(
2.01%
)
Dow Jones
38,686.62
(
1.21%
)
Brent Oil
82.78
(
-1.02%
)
Bitcoin
61,897.58
(
4.70%
)
Post# of 251700
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 56
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: xrymd post# 124384

Thursday, 08/04/2011 12:30:06 AM

Thursday, August 04, 2011 12:30:06 AM

Post# of 251700
lol. I was talking per dose. I guarantee if the patient refuses the first one, the doc won't order the 2nd or 3rd!

More seriously, it is important to note docs are not charged for the total treatment. Only for doses actually delivered. If it gets lost in delivery or arrives past the 18-expiry, That's DNDN's loss. Same with inbound apheresis material since DNDN absorbs all those costs in their effort to avoid the BEXXAR nightmare.

Unless otherwise indicated, this is the personal viewpoint of David
Miller and not necessarily that of Biotech Stock Research, LLC.
We're on Twitter at BiotechStockRsr

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up